CTOs on the Move

DTx Inc.

www.dtx.com

 
DTx Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Melbourne, FL. To find more information about DTx Inc., please visit www.dtx.com.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.dtx.com

  • Melbourne, FL USA 32901-2643
  • Phone: 321.728.0172

Executives

Name Title Contact Details

Similar Companies

Westpak Inc

Westpak Inc is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Frontage Laboratories

Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.

Clinex Retina Resource

Clinex Retina Resource, LLC is a Augusta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JJ WIld

JJ WIld is a Canton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.